A joint effort over a period of time: factors affecting use of urate-lowering therapy for long-term treatment of gout

BMC Musculoskelet Disord. 2016 Jun 6:17:249. doi: 10.1186/s12891-016-1117-5.

Abstract

Background: Although international guidelines encourage urate lowering therapy (ULT) for people who have more than two attacks of gout, only 30 % of patients are prescribed it and only 40 % of those adhere to the treatment. The aim was to explore reasons for this through an exploration of patient experience and understanding of ULT treatment for gout.

Methods: A qualitative study was conducted throughout the United Kingdom. Narrative and semi-structured video-recorded interviews and thematic analysis were used.

Results: Participants talked about their views and experiences of treatment, and the factors that affected their use of ULT. The analysis revealed five main themes: 1) knowledge and understanding of gout and its treatment; 2) resistance to taking medication; 3) uncertainty about when to start ULT; 4) experiences of using ULT; and 5) desire for information and monitoring.

Conclusion: Patients' understanding and experiences of gout and ULT are complex and it is important for clinicians to be aware of these when working with patients. It is also important for clinicians to know that patients' perceptions and behaviour are not fixed, but can change over time, with changes to their condition, with dialogue and increased understanding. Patients want this interaction with their clinicians, through "a joint effort over a period of time".

Keywords: Gout; Patient perceptions; Primary care; Qualitative; Urate lowering therapy (ULT).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Allopurinol / administration & dosage
  • Allopurinol / adverse effects
  • Allopurinol / therapeutic use
  • Cooperative Behavior*
  • Female
  • Gout / blood
  • Gout / drug therapy*
  • Gout Suppressants / administration & dosage
  • Gout Suppressants / adverse effects
  • Gout Suppressants / therapeutic use*
  • Health Knowledge, Attitudes, Practice*
  • Humans
  • Long-Term Care / methods
  • Male
  • Medication Adherence*
  • Middle Aged
  • Motivation
  • Physician-Patient Relations*
  • Practice Guidelines as Topic
  • Qualitative Research
  • Rheumatologists / psychology
  • United Kingdom
  • Uric Acid / blood
  • Uric Acid / metabolism

Substances

  • Gout Suppressants
  • Uric Acid
  • Allopurinol